Related Experiment Video
Updated: Oct 14, 2025
16:08
Microinjection of CRISPR/Cas9 Protein into Channel Catfish, Ictalurus punctatus, Embryos for Gene Editing
Published on: January 20, 2018
15.2K
Ichthyosiform changes in a patient with RAC1 mutation.
Isabel Mary Haugh1, Juliana L Pineider2, Nnenna Gebechi Agim1
1Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Pediatric Dermatology
|November 2, 2021
Summary
RAS-related C3 Botulinum Toxin Substrate 1 (RAC1) mutations are rare. This study details the first known RAC1 mutation case presenting with ichthyosiform changes, expanding knowledge of its cutaneous effects.
Area of Science:
- Genetics and Molecular Biology
- Dermatology
- Developmental Biology
Background:
- RAS-related C3 Botulinum Toxin Substrate 1 (RAC1) is a Rho GTPase crucial for cellular functions like gene regulation and actin dynamics.
- Known RAC1 mutations are infrequent, typically causing developmental delays and brain abnormalities.
- While hair loss is a known phenotype in Rac1 knockout mice, other skin-related effects remain understudied.
Observation:
- This report documents the first identified case of a patient with a RAC1 mutation exhibiting ichthyosiform changes.
- Ichthyosis is a group of skin disorders characterized by dry, scaling skin.
Findings:
- A novel RAC1 mutation was identified in a patient presenting with ichthyosis.
- This finding links RAC1 mutations to a previously unrecognized cutaneous phenotype.
Implications:
- This case expands the known clinical spectrum of RAC1-related disorders.
- Further research into RAC1's role in skin development and maintenance is warranted.
- Understanding these mutations may lead to new diagnostic or therapeutic strategies for related conditions.
